glp 1 def GLP-1 Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH Compounded" GLP-1 drugs | Health
Description
278 Importantly, GLP-1 RAs also exhibit neuroprotective potential
GLP-1 RAs also interact with the renin-angiotensin-aldosterone system (RAAS) but consistent changes in angiotensin II or aldosterone levels have not been demonstrated
As of April 2026, compounded GLP-1 medications remain available through certain pharmacy pathways, though the landscape has contracted compared to 2023 and 2024 following regulatory changes
W.SinghS.NelsonC
Methods This was a multicentre retrospective observational study on new users of diabetes medications
This is less than semaglutide (Rybelsus 15-17%) and high-dose Wegovy injection 15-18%
